home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

11th Annual Proteins & Antibodies Congress

 
  August 23, 2017  
     
 
Oxford Global Conferences, London
16th - 17th April 2018


Oxford Global Conferences are proud to present our 11th Annual Proteins & Antibodies Congress, 16-17 April 2018, London, UK with our co-located 5th Annual Peptides Congress and 5th Annual Biosimilars & Biobetters Congress. Across the two days, over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

Including 5 interactive streams:

  • Protein Engineering, Design & Selection
  • Biotherapeutics: Manufacturing, Chemistry, Analytics and Control
  • Antibody Engineering, Design & Development
  • Cloning, Expressions, Purification & Analytics
  • Protein & Antibody Biotherapeutics

Download Agenda: http://bit.ly/2iqjUH3

 

Free Live Webinars

Protein & Antibody Biotherapeutics – Manufacturing & Developability Assessment
Hosted by
David Gervais, Head of Product Development, Porton Biopharma and Thorsten Lorenz, Group Head Developability Assessment 1, Novartis
Register for Free Today: http://bit.ly/2g4nJRl  

Antibody Biotherapeutics: Current Technologies And Recent Therapeutic Success
Hosted by David Mantus, Chief Development Officer,
Arsanis and Pallavi Tawde, Single B Cell Cloning Platform Leader, Bristol-Myers Squibb
Register for Free Today: http://bit.ly/2wnmDqw   

For further information regarding prices and possible discounts, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call +44 (0)1865 248 455.

 

 
 
Organized by: Oxford Global Conferences
Invited Speakers:

Roy Baynes, Chief Medical Officer, Senior Vice President and Head of Global Clinical Development
Merck & Co., Inc.

David Mantus, Chief Development Officer
Arsanis

Jens Frauenfeld, Chief Executive Officer
Salipro Biotech AB

Yanay Ofran, Chief Executive Officer & Founder and Professor of Biophysics and Computational Biology
Biolojic Design and Bar-Ilan University

Steffen Nock, Senior Vice President (Global Biologics Head)
Teva Pharmaceuticals

Syd Johnson, Vice President, Antibody Engineering
Macrogenics

Annelise Vuidepot, Vice President, Head of Oncology Pipeline and Research
Immunocore

Sanjaya Singh, Vice President and Head, Biotherapeutics
Johnson & Johnson

Hari Hariharan, Senior Director, Biotherapeutics
Celgene

Angela Norton, Senior Director and Head, Protein & Antibody Engineering
Shire Pharmaceuticals

Zhulun Wang, Executive Director, Research
Amgen

Michelle Morrow, Director, Preclinical Translational Pharmacology
F-Star Biotechnology

Sujata Sharma, Director, Protein Science
Merck & Co., Inc.

Emma Harding, Director, Head of Molecular Design and Engineering
GlaxoSmithKline

Ai Ching Lim, Director, Research
Amgen

Andy Hooker, Director of Pharmaceutical Sciences
Ipsen Bioinnovation Ltd

Kenneth Walker, Director of Research, Biologics
Amgen

Claire Dobson, Associate Director, Antibody Discovery and Protein Expression
MedImmune

Yung-Hsiang Kao, Associate Director and Principal Scientist
Genentech

W. Blaine Stine, Associate Director, Discovery Biologics
AbbVie

Patrick Garidel, Associate Director, Protein Chemistry
Boehringer Ingelheim

Stefan Weigand, Global Head of Large Molecule Research
F.Hoffmann-La Roche

Katarina Radošević, Global Head Biologics Research
Sanofi R&D

Thorsten Lorenz, Group Head Developability Assessment 1
Novartis

David Gervais, Head of Product Development
Porton Biopharma

Alexey Rak, Head, BioStructure & Biophysics
Sanofi

Darko Skegro, Senior Team Leader
Novartis

Sharon McGonigle, Senior Principal Scientist
Eisai

Michael Chin, Senior Principal Scientist and Associate Research Fellow
Pfizer

Tina Møller Tagmose, Principal Scientist
Novo Nordisk A/S

Jane Seagal, Principal Research Scientist
AbbVie

Sepideh Afshar, Principal Research Scientist, Department of Protein Engineering
Eli Lilly & Company

Sally Fischer, Principal Scientist and Group Leader
Genentech

Carsten Behrens, Principal Scientist
Novo Nordisk A/S

Berthold Boedeker, Chief Scientist and Project Coordination
Bayer AG

Ren Liu, Team Leader and Associate Principal Scientist
Merck & Co., Inc.

Dorina Saro, Senior Research Scientist
Johnson & Johnson

Pallavi Tawde, Single B Cell Cloning Platform Leader
Bristol-Myers Squibb

Christopher Lloyds, Senior Scientist, Senior Scientist, Protein Engineering
MedImmune

Kaimeng Zhou, Analytical Team Lead
Bristol-Myers Squibb

Christian Bernloehr, Project Leader, Molecular Biology Department
Boehringer Ingelheim

Zhi Chen, Senior Scientist, Molecular and Analytical Development, Global Manufacturing & Supply
Bristol-Myers Squibb

Kerstin Otte, Professor
University of Applied Sciences Biberach

Jon Sayers, Professor of Functional Genomics
University of Sheffield

Alexander Golovanov, Senior Lecturer and Principal Investigator
Manchester Institute of Biotechnology and School of Chemistry, University of Manchester

 
Deadline for Abstracts: N/A
 
Registration:

Register today: http://bit.ly/2xsqcZ6

E-mail: d.dalby@oxfordglobal.co.uk
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.